The results also showed that the immunoreactivity of CD151 was localized to the plasma membrane of the tumor cells and that the intensity of CD151 immunoreactivity in the HCC tissues was stronger than that in the paratumoral samples (Figure 2B and C, p<0.01). The gene discussed is CD151; the disease is hepatocellular carcinoma.